September 16, 2022 SRH PM&R Grand Rounds 2022-2023: Leveraging Theory and Qualitative Methods to Promote Patient-Centered TBI Clinical Care - Archived
Description
This lecture will describe the evidence surrounding disparities in TBI care that exist across the continuum of care and highlight the role of qualitative research methods for identifying and comprehensively synthesizing patients’ perceptions of factors meaningfully linked to positive and negative outcomes. It will also describe the role of theories of adjustment (Intersectional Ecological Models, Minority Stress Theory, Double ABC-X Model) and their utility in informing clinical research, assessment, and case conceptualization. Finally, clinical tools that promote more a detailed understanding of patients’ identities will be discussed, including the Structural Vulnerability Assessment Tool and Salient Circles Diagram exercise.
Course Director: Mel Glenn, MD
For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at partnerscpd@partners.org.
You may print individual certificates throughout the year; your cumulative list of completed activities is accessible on your transcript.
Target Audience
This activity is intended for MDs, at the Spaulding Rehabilitation Hospital
Learning Objectives
Upon completion of this activity, participants will be able to:
- Participants will enhance their understanding of theories of adjustment relevant to TBI outcomes and their combination with qualitative methods
- Participants will improve their awareness of the use of meta-syntheses to comprehensively characterize existing research that leverages patients’ perspectives
- Participants will be able to identify and utilize clinical tools that assess patients’ perspectives of salient aspects of their identities and factors linked to their recovery
Additional Information
Mass General Brigham
Course Director
Mel Glenn, MD, PhD
Chief, Brain Injury Division,
Massachusetts General Hospital
Faculty
Sarah Bannon, PhD
Clinical Health Psychologist,
Massachusetts General Hospital
DISCLOSURE SUMMARY OF RELEVANT FINANCIAL RELATIONSHIPS
INELIGIBLE COMPANIES
Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Examples of such organizations include:
- Advertising, marketing, or communication firms whose clients are ineligible companies
- Bio-medical startups that have begun a governmental regulatory approval process
- Compounding pharmacies that manufacture proprietary compounds
- Device manufacturers or distributors
- Diagnostic labs that sell proprietary products
- Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
- Manufacturers of health-related wearable products
- Pharmaceutical companies or distributors
- Pharmacy benefit managers
- Reagent manufacturers or sellers
For more information: https://accme.org/faq/what-accmes-definition-ineligible-company
MITIGATION STRATEGIES
Mass General Brigham has implemented a process to mitigate relevant financial relationships for this continuing education (CE) activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public.
The following planners reported no relevant financial relationship with an ineligible company:
Jason Frankel, MD
Mel Glenn, MD, PhD
Jeffrey Schneider, MD
The following speaker reported no relevant financial relationship with an ineligible company:
Sarah Bannon, PhD
ACCREDITATION
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 CreditTM
Mass General Brigham designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation